Hayat S. Khogali

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action.

Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action.

Journal: Expert review of anti-infective therapy

Published: July 20, 2026

Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV).

Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV).

Journal: Human vaccines & immunotherapeutics

Published: February 12, 2026

Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.

Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.

Journal: Women's health (London, England)

Published: January 29, 2024

Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12-17 Years against COVID-19 Infection in Qatar.

Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12-17 Years against COVID-19 Infection in Qatar.

Journal: Vaccines

Published: July 12, 2023

Key Lessons from COVID-19: A Narrative Review Describing Qatar's Multifactorial Approach in Executing a Vaccination Campaign.

Key Lessons from COVID-19: A Narrative Review Describing Qatar's Multifactorial Approach in Executing a Vaccination Campaign.

Journal: Vaccines

Published: February 14, 2023

Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.

Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.

Journal: Vaccines

Published: May 16, 2022

Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.

Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.

Journal: Epidemiology and infection

Published: September 14, 2021

Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.

Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.

Journal: Epidemiology and infection

Published: July 02, 2021

Validation of rapid antibody (IgG-IgM) test kit for SARS-CoV-2 infection in Qatar.

Validation of rapid antibody (IgG-IgM) test kit for SARS-CoV-2 infection in Qatar.

Journal: Journal of public health research

Published: May 28, 2021

Can the cycle threshold (Ct) value of RT-PCR test for SARS CoV2 predict infectivity among close contacts?

Can the cycle threshold (Ct) value of RT-PCR test for SARS CoV2 predict infectivity among close contacts?

Journal: Journal of infection and public health

Published: March 23, 2021

Bordetella pertussis: An agent not to be forgotten in Qatar.

Bordetella pertussis: An agent not to be forgotten in Qatar.

Journal: Qatar medical journal

Published: November 24, 2020

Assessment of Cabin Crew Awareness about Malaria in a Major Airline.

Assessment of Cabin Crew Awareness about Malaria in a Major Airline.

Journal: Mediterranean journal of hematology and infectious diseases

Published: April 30, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026